Company founder and CEO, Travis Leonardi, RPh, CP, has more than 30 years of experience in healthcare. A serial entrepreneur and pharmacist, he has founded several companies, all within the healthcare industry. His clinical expertise, combined with his business and leadership experience, has made him acutely aware of what it takes to gather critical information from difficult environments. He is a graduate of St. John’s Pharmacy School in New York.
Before becoming Sentry’s Chief Pharmacy Officer, Dawn DeAngelo, BS, PharmD, held leadership positions with Sentry’s sales and client services teams after spending more than 18 years in clinical and operational roles in hospital pharmacy. At Cardinal Health, she managed multiple hospital pharmacies and consulted for large health care institutions across the country. At Sentry, she collaborates on Sentry product development, drawing from the insight learned from our customers and from her own pharmacy operations experience. She also supports client projects and Sentry’s internal operations involving pharmacy financial and clinical analytics, pharmacy operations, and optimization of 340B. Dawn earned her Doctorate of Pharmacy and Bachelor of Science in Pharmacy from Duquesne University in Pittsburgh.
Kim Jacques, Chief Information Officer, has spent more than 35 years in the IT field. Prior to her role at Sentry, Kim served in roles such as chief information officer and IT director for national companies both large and small. Her experience has included global implementation of BPM, CRM, BI and DW solutions, data center scaling, and merger and acquisition support. Throughout her career, Kim has ensured regulatory compliance and delivered customer-focused IT services through innovative technology integration and successful leadership of diverse global and virtual teams. Kim has been published in technology magazines Sync and In$urance CIO Outlook and speaks regularly at educational institutions to inspire women to pursue IT careers. Kim is responsible for Sentry’s entire data infrastructure, technical client support, and overseeing and executing innovative IT improvements. She holds an undergraduate degree in business from the University of Virginia and earned her MBA from Boston University.
Ron Linares, Chief Financial Officer, has served as a senior financial manager for over 25 years in various privately-held, publicly-traded and private equity-owned firms, with a focus primarily in the areas of software and life sciences. Ron is skilled in strategic planning, management consulting, financial analysis and reporting, mergers and acquisitions and project management. In his current role at Sentry, he is responsible for the accounting, finance, financial analysis and human resources teams. Ron received his B.S from the University of Florida, his Master’s in public accountancy from Barry University and his Doctor of Business Administration from Nova Southeastern University in Ft. Lauderdale, FL.
Lidia Rodriguez-Hupp brings more than 18 years’ experience in 340B software and program maintenance, and six years in various staff positions within the US House of Representatives, to her position as Chief of Corporate Initiatives, 340B Compliance Officer and Senior Vice President. Lidia currently serves as an Advisory Board Committee Member for IPMI’s Healthcare Law & Compliance Institute, where she is instrumental in helping to shape program content.
Lisa Scholz, Head of Industry Relations, joined Sentry after three years as Chief Operating Officer and Senior Vice President at 340B Health, a membership organization of more than 1,200 public and private nonprofit hospitals and health systems throughout the U.S. During her tenure, she grew the association’s membership, guided strategy, and helped influence legislative decisions to affect program change. Dr. Scholz also spent over 20 years working as a pharmacist, pharmacy operations manager and director of pharmacy at a 1,000-bed hospital health system in Texas and served as Vice President of the HRSA Pharmacy Services Support Center at the American Pharmacists Association (APhA), where she secured a five-year contract to provide HRSA’s Office of Pharmacy Affairs (OPA) with assistance and expertise in the delivery of pharmaceutical services and 340B support. She volunteers to support the University of Houston College of Pharmacy Dean’s Advisory Council and chairs the Advocacy committee for the APhA Care of Underserved Special Interest Group. Her roles at Sentry include stakeholder relationships, government and public relations, internal and external training and education, communications and customer experience. Dr. Scholz has both a doctorate in pharmacy from the University of Houston and an MBA from Madison University. She is a registered pharmacist and pharmacist preceptor in Texas, University of Phoenix graduate school faculty, and recently received Fellow designation from the American College of Healthcare Executives.
William Sander, Chief Revenue Officer, joined Sentry more than 10 years ago. William is an accomplished leader and PharmD with more than 25 years in the healthcare industry. He began his career as a director of pharmacy and quickly progressed, gaining experience in diverse roles such as director of radiology, corporate director of pharmacy and vice president of a pharmacy outsourcing company. He then transitioned his career to sales, where he has held various leadership positions. Since coming to Sentry, William has been highly engaged with Sentry’s political advocacy efforts to protect the 340B program and frequently visits Washington DC to educate stakeholders. In his current role, he is responsible for managing customer relationships in addition to market expansion. William earned his PharmD from St. Louis College of Pharmacy.